BACKGROUND: Timing and stability of the sleep-wake cycle are potential modifiable risk factors for cardiometabolic disease. The aim of this study was to evaluate the relationship between objective measures of sleep-wake timing and stability with cardiometabolic disease risk.
Cardiometabolic diseases (CMDs), including obesity, diabetes, and hypertension, are leading causes of morbidity and mortality worldwide, and they disproportionately affect Hispanic/Latino individuals. 1, 2 Many risk factors for CMDs can be addressed with varying degrees of success through a combination of medication and lifestyle changes. 3, 4 There is growing interest in identifying novel risk factors for CMDs that can serve as additional targets for prevention and disease modification.
Short sleep duration has previously been shown to be associated with an increased incidence of hypertension in healthy individuals 5 and in those with insomnia. 6 In addition, short sleep duration has been associated with increased BMI, 7 impaired glucose tolerance, 8 and increased odds of developing diabetes. 9, 10 More recently, decreased sleep efficiency and increased sleep fragmentation were also shown to be associated with an increased prevalence of hypertension.
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Along with sleep duration and quality, there is growing evidence that the stability and timing of the sleep-wake cycle are important predictors of cardiometabolic risk.
Greater day-to-day instability of the daily activity rhythm, as assessed by the interdaily stability measure, has been associated with a higher risk of obesity, diabetes, hypertension, and hyperlipidemia in older adults. 12 In addition, the timing of sleep-wake patterns may also contribute to CMD risk. Many individuals experience the phenomenon of "social jet lag," in which sleep-wake timing differs significantly between work days and nonwork days. 13 Increased social jet lag has been associated with higher BMI in individuals who are overweight or obese. 14 In addition, individuals with diabetes and a later midpoint of sleep have higher glycosylated hemoglobin values, indicating poorer glucose control. 15 Finally, shift work is one of the most obvious sources of disruption to sleep-wake timing and has also been shown to increase the risk of CMD. Among Hispanic/Latino individuals, 27.7% work alternative (non-day) shifts, 16 and thus this population is likely to have a higher instability of sleep-wake timing, which may contribute to the observed CMD risk.
In a large community-based sample of Hispanic/Latino adults from the Hispanic Community Health Study/ Study of Latinos (HCHS/SOL), the present study used objective measures of interdaily stability and sleep-wake timing to examine the cross-sectional associations of stability and timing of sleep with CMD risk factors. We hypothesized that greater disruption of the timing of the sleep-wake schedule, reflected in either later sleep timing, increased social jet lag, or lower interdaily stability of actigraphically measured sleep timing, would be associated with higher CMD risk as measured according to BP, BMI, and glucose control. Furthermore, it was assumed that this group would be a population with a high prevalence of shift work.
Patients and Methods

Study Cohort
The HCHS/SOL is a community-based cohort study of 16,415 selfidentified Hispanic/Latino adults, recruited between 2008 and 2011 from randomly selected households at four US field centers (Bronx, New York; Chicago, Illinois; Miami, Florida; and San Diego, California). The multistage sampling design and cohort selection procedures have been previously described. 17, 18 As part of the baseline examination, all participants not previously diagnosed with diabetes underwent an oral glucose tolerance test. Fasting blood samples were collected on arrival for assay of glucose, insulin, and glycosylated hemoglobin, with glucose measured a second time 120 min following oral glucose ingestion. BP was measured in the seated position by using an automated sphygmomanometer following an initial 5-min rest period. Results were reported as the average of three BP readings, taken 1 min apart. All BP recordings occurred in the morning, during the second hour of the 7-h baseline study examination. In addition, sleep apnea severity was assessed by using a home monitoring system as previously described. 19 Levels of education and acculturation (defined based on place of birth and duration of time living in the United States), as well as current work schedule, were assessed through the use of questionnaires.
The Sueño sleep ancillary study recruited 2,252 individuals who were within 30 months of their baseline HCHS/SOL examination (median, 823 days) from December 2010 to December 2013. Participants were aged 18 to 64 years, did not have narcolepsy (according to history), an apnea-hypopnea index (AHI) $ 50 events per hour, and were not using nocturnal positive airway pressure therapy. Individuals were not excluded if they had insomnia, restless leg syndrome, shift work, or other sleep disorders not specified earlier. reading/coordinating center) (e-Appendix 1), and all participants provided written informed consent.
Sueño Study Protocol
As part of the Sueño ancillary study, all participants completed a questionnaire that included self-reported medical history, current medications, Hispanic/Latino background, household income, and employment status. Height and weight were measured at the time of this visit. Staff-administered questionnaires were completed in either English or Spanish depending on the language preference of the participant.
Actigraphy
All participants in the Sueño ancillary study were asked to wear an Actiwatch Spectrum (Philips Respironics) device on their nondominant wrist for 7 days. Participants were asked to not remove the watch for the duration of the study and were instructed to press the event marker button upon getting into or out of bed. They also completed a sleep diary each morning indicating time into bed, time out of bed, any naps taken the previous day, and whether each day was a free day or a work day.
The actigraph units were programmed to collect activity data in 30-s epochs. Each actigraph was manually scored for the main rest interval and any nap intervals using standardized criteria detailed previously. 20 Once rest intervals were defined, sleep was scored by using the Actiware 5.59 algorithm (5 immobile minutes for sleep onset, 0 immobile minutes for sleep offset, wake threshold count of 40). 21 Any day of recording with > 4 h of missing data during the 24-h window, or > 2 min of missing data during a main rest interval, was considered invalid. For analyses of sleep midpoint, only individuals with $ 5 valid days were included (n ¼ 2,156); for analyses of interdaily stability, only individuals with 7 consecutive days of valid data were included (n ¼ 1,694) to allow for sampling of both work and nonwork days. If participants collected > 7 days of data, only the first 7 consecutive days of valid actigraphy data were used.
Definitions
Actigraphic variables measured were as follows: mean sleep onset time, mean sleep offset time, mean sleep midpoint time, and interdaily stability. Sleep midpoint was calculated as the midpoint between sleep onset and sleep offset, determined for both weekdays (Sunday through Thursday) and weekends (Friday and Saturday). Social jet lag was defined as the difference between the mid-sleep point on weekdays and weekends.
14 Sleep duration was calculated as the sum of all epochs of sleep between sleep onset and sleep offset, averaged across all days. These measures were all based on the primary sleep period. The interdaily stability index quantifies the regularity of sleep patterns across days and provides a measure of how stable sleepwake rhythms are from day to day.
A similar metric has been previously described for assessing stability of activity rhythms across the day, where each day is divided into 24 onehour bins, and the variance in activity explained by these bins is compared with the total variance. 22, 23 The focus of the present study was on the variance in the dichotomous variable of the sleep/wake state; we divided the variance into two components: one explained by the hour of the day (between-hour variance) and the other the residual variance within each hour bin (within-hour variance). The interdaily stability was calculated as the between-hour variance to total (between-hour plus within-hour) variance. Interdaily stability can range from 0% to 100%, with 0% indicating very unstable sleepwake patterns from day to day, and 100% indicating very stable sleep-wake patterns from day to day. This measure incorporates both the primary sleep period and any napping that might occur during the day.
BMI was calculated by using height and weight measured at the time of the Sueño study visit. Obesity was defined as BMI $ 30 kg/m 2 . Hypertension was defined from information provided at the time of the Sueño study visit, based on self-report of a diagnosis of hypertension or currently taking antihypertensive medications. Information regarding glycemic control and BP were obtained from the baseline HCHS/SOL study examination for each participant. Diabetes was defined as fasting glucose levels $ 126 mg/dL at > 8 h of fasting or > 200 mg/dL at < 8 h of fasting, glucose levels $ 200 mg/dL following the oral glucose tolerance test, glycosylated hemoglobin values $ 6.5%, or the use of an antidiabetes medication.
Statistical Methods
Survey linear regression was performed to examine the associations between sleep timing variables and continuous response variables, including systolic BP (SBP), diastolic BP (DBP), and BMI using sampling weights to account for the study design and probability of participating in the study. Values for skewed response variables (homeostatic assessment of insulin resistance and glycosylated hemoglobin) were log transformed prior to regression analysis. Survey linear regression was also used for dichotomous outcomes (eg, hypertension, diabetes) modeling the prevalence of each response. 24 We first considered a regression model adjusting for age, sex, Hispanic/Latino background, and study site (Model 1). Model 2 adjusted for covariates in Model 1, plus income, acculturation, education level, sleep duration, and AHI. Finally, Model 3 adjusted for covariates in Model 2, plus shift work status. All statistical tests were 2-sided at a significance level of .05. Analyses were performed by using SAS version 9.4 (SAS Institute, Inc).
Results
A total of 2,156 participants had actigraphy data available for this analysis (Fig 1) . Their mean age was 47 years, 65% were women, and 767 (36%) had a diagnosis of hypertension. Table 1 provides age-and sex-standardized (based on the 2010 US Census) comparisons of those with and without hypertension. Individuals with hypertension were more likely to be unemployed, have lower household income, and to have not been born in the United States. Notably, 21% of the participants were shift workers, whereas 42% were unemployed. Table 2 presents age-and sexstandardized sleep measures according to hypertension status. Average sleep onset was 0:01 AE 0:04 on weekdays and 0:43 AE 0:04 on weekends. Average sleep midpoint was 3:48 AE 0:04 on weekdays, and 4:38 AE 0:04 on weekends. Interdaily stability ranged from 5% to 97%, with a mean of 75%. Individuals with hypertension had a significantly lower interdaily stability (73% vs 76%; P < .05). Table 3 presents regression coefficients of the association between sleep variables and hypertension prevalence and SBP and DBP. Each 10% decrease in interdaily stability was associated with a 3.0% increase in the prevalence of hypertension (95% CI, 0.6-5.3; P < .05), a 0.78 mm Hg increase in SBP (95% CI, 0.12-1.45; P < .05), and a 0.80 mm Hg increase in DBP (95% CI, 0.28-1.32; P < .01). Associations remained significant after adjusting for age, sex, background, and site. When income, acculturation, education, sleep duration, and AHI were added to the models, associations with DBP remained significant (but not hypertension and SBP). Associations did not remain significant after adding shift work to the model. Each 1-h delay in sleep midpoint was associated with a 0.73 mm Hg increase in SBP (95% CI, 0.30-1.16; P < .01) and a 0.53 mm Hg increase in DBP (95% CI, 0.06-0.76; P < .01). These associations remained significant after adjusting for age, sex, background, site, income, acculturation, sleep duration, and AHI but not after adjusting for shift work status. There was no association between social jet lag and any of the BP measures. Table 4 presents regression coefficients of the association between the actigraphically measured sleep variables with BMI, glucose control, and the prevalence of diabetes. No association was found between actigraphically measured sleep timing variables and diabetes, BMI, log of homeostatic assessment of insulin resistance, or log of glycosylated hemoglobin. Table 5 presents regression coefficients of the association between sleep variables and hypertension prevalence and SBP and DBP, stratified according to shift work status. Associations between hypertension and interdaily stability remained significant in the non-shift-work group. In addition, associations between SBP and sleep midpoint, and DBP and sleep midpoint, remained significant in the non-shift-work group.
Discussion
In this observational study using objective data to evaluate sleep timing and stability in US Hispanic/Latino subjects, decreased interdaily stability was associated with an increased risk of hypertension and greater objectively measured SBP and DBP. In addition, later sleep-wake timing, as measured by the midpoint of sleep, was associated with higher objectively measured SBP and DBP. Although the clinical impact of sleepwake timing and stability on BP may not be apparent, at a population level, these differences can be meaningful. For example, a large meta-analysis evaluating the use of antihypertensive agents in the prevention of cardiovascular disease showed that decreases in SBP by 1 mm Hg and DBP by 0.5 mm Hg (similar to the magnitude of difference seen in our study) were associated with a 4% decrease in stroke and a 2% decrease in coronary heart disease events. 25 These results reflect the importance of optimizing both the timing and regularity of the sleep-wake cycle in promoting overall cardiovascular health.
BP is under prominent circadian control, typically measuring higher during the day and dipping in the middle of the night. Loss of this normal dipping pattern is believed to be a better predictor of CMD risk and mortality than an isolated elevated BP reading during the day. 26 A potential mechanism for interdaily stability to contribute to hypertension risk is through disruption of this normal dipping pattern. With increased interdaily stability, day-to-day timing of exposure to light and other circadian environmental entraining signals, which are important for proper alignment between the internal circadian clock and environment, becomes more regular. As a result, it is more likely that the circadian clock will be stably aligned to the environment, in turn leading to better sleep quality. In support of this hypothesis, data have shown loss of nocturnal dipping of BP in shift workers, a group more likely to have decreased interdaily stability and circadian misalignment. 27 Experimental models of shift work have shown that mean arterial BP increases by 3% in chestjournal.org individuals with sleep-wake cycles that are misaligned with the external environment, independent of changes in norepinephrine or epinephrine. 28 There are far fewer data regarding interdaily stability and CMD risk in healthy non-shift workers. Our results are similar to those found in the Rush Memory and Aging Project, which reported an association between decreased interdaily stability and increased risk for hypertension 12 ;
however, we have reported greater generalizability of those findings through our population-based study.
As expected, the associations between sleep timing and hypertension did not remain after adjusting for shift work status but remained present in the non-shift-work group, which included individuals who worked day shifts or were unemployed. Of note, 42% of the overall study population was unemployed, and 52% of the hypertensive population was unemployed, suggesting that the unemployed group was the primary driver of this association. Although many factors may contribute to higher levels of hypertension in the unemployed population, these data suggest that the greater variability of sleep-wake timing that accompanies the lack of a fixed daily schedule imposed by work may be an important additional factor.
Unlike previous studies, our data found no associations between sleep timing or interdaily stability and diabetes, BMI, or insulin resistance. 14, 15 Of note, several of the cardiometabolic risk factors in our study were obtained Values were weighted for survey design and nonresponse and adjusted to the age and sex distribution of the 2010 US Census.
up to 30 months prior to actigraphy. However, this factor does not explain the lack of association with BMI, which was obtained at the same time as the actigraphy assessment. Because interdaily stability and circadian misalignment (either experimentally induced 28 or measured by using melatonin levels as a proxy 29 ) have previously been shown to precede the development of adverse health effects, it is possible that sampling actigraphy several months following the assessment of insulin resistance may have underestimated the magnitude of the association.
The primary limitation of the present study is that many of the cardiometabolic assessments, including BP measurements, were obtained several months prior to the time of actigraphy assessment. Although we are presumably assessing the long-term health effects of these behaviors in this study, it is possible that sleepwake timing and stability may have changed between the initial assessment and the time of the actigraphy measurements. In addition, with a single time point, it is not possible to determine whether the observed changes in sleep-wake timing and stability are the cause or a downstream effect of hypertension. However, the advantage of this longitudinal cohort is that we have the opportunity to perform additional assessments for prospective analyses in the future.
In addition, it should be noted that objective BP measurements were based on averaged readings obtained at a single time point, rather than a reflection of the 24-h profile of BP. It is known that the loss of a circadian pattern of nocturnal dipping of BP may be associated with greater risk for CMD than an isolated high reading during the day. 30 With that in mind, future studies evaluating the association between actigraphically measured rest-activity patterns and 24 h profiles of BP would be useful. We are also unable to comment specifically on the use of beta-blockers and hypnotic agents in this population, which could potentially affect sleep and circadian rhythms in these individuals. 31 Finally, it should be noted that although the unique aspect of this cohort is that it provides information regarding cardiometabolic risk factors in a Hispanic population with a large proportion of individuals who are either shift workers, unemployed, or not following a conventional work schedule, these factors also potentially limit the generalizability of the findings to the general population.
In future directions, further characterization is needed of the mechanisms underlying these observed associations between disrupted sleep-wake timing and hypertension, including evaluation of 24-h BP profiles, melatonin levels, and the use of medications that may disrupt melatonin production. In addition, interventions are needed to determine whether therapies aimed at improving interdaily stability and adjusting sleep midpoint can improve BP.
Conclusions
We observed that the timing and regularity of sleepwake schedules were associated with hypertension. These findings suggest that interventions aimed at improving the timing of sleep may be important targets for decreasing cardiometabolic disease risk. chestjournal.org
